INGRAALYS

INGRAALYS is a research-driven start-up advancing the next generation of anti-aging skincare. We provide cosmetic companies with cutting-edge biological tools to evaluate the efficacy and safety of their products—faster, deeper, and with scientific rigor. Our core strengths lie in: • Human skin cell culture (keratinocytes, fibroblasts, melanocytes) • Ex vivo skin explant testing • Cellular reprogramming models targeting aged/senescent cells • RNA sequencing and gene expression profiling • Histological and immunofluorescence analysis Founded in 2017 by Dr. Claude Chauchard, INGRAALYS is headquartered within the CYBORG incubator at the IRMB (Institute for Regenerative Medicine and Biotherapies), where our scientific partner Prof. Jean-Marc Lemaitre leads a world-renowned research team on genome and stem cell plasticity in aging. This partnership is rooted in nearly two decades of INSERM-backed academic research (AVENIR Program, IRMB/U1183) on reversing cellular aging through reprogramming strategies. These findings now power our testing platforms and innovation pipeline. For collaboration or inquiries, contact us at: ingraalys1@orange.fr